img

Global Pediatric Clinical Trials Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Pediatric Clinical Trials Market Research Report 2024

According to MRAResearch’s new survey, global Pediatric Clinical Trials market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pediatric Clinical Trials market research.
Key companies engaged in the Pediatric Clinical Trials industry include IQVIA Holdings, Inc., Parexel International, CenterWatch, Syneos Health, Charles River Laboratories, Covance Inc., ICON Plc., Pharmaceutical Product Development, LLC. and Genentech (Roche), etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Pediatric Clinical Trials were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pediatric Clinical Trials market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Pediatric Clinical Trials market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


IQVIA Holdings, Inc.
Parexel International
CenterWatch
Syneos Health
Charles River Laboratories
Covance Inc.
ICON Plc.
Pharmaceutical Product Development, LLC.
Genentech (Roche)
Pfizer
Bristol-Myers Squibb
GlaxoSmithKline
Sanofi S.A.
Novartis AG
Johnson & Johnson
Shire (Takeda)
Segment by Type
Pre-Clinical Phase
Phase I
Phase II
Phase III

Segment by Application


Neuropsychiatric Conditions
Infectious Diseases
Respiratory Diseases
Cardiovascular Diseases
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pediatric Clinical Trials report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Clinical Trials Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Pre-Clinical Phase
1.2.3 Phase I
1.2.4 Phase II
1.2.5 Phase III
1.3 Market by Application
1.3.1 Global Pediatric Clinical Trials Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Neuropsychiatric Conditions
1.3.3 Infectious Diseases
1.3.4 Respiratory Diseases
1.3.5 Cardiovascular Diseases
1.3.6 Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Clinical Trials Market Perspective (2018-2033)
2.2 Pediatric Clinical Trials Growth Trends by Region
2.2.1 Global Pediatric Clinical Trials Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Pediatric Clinical Trials Historic Market Size by Region (2018-2023)
2.2.3 Pediatric Clinical Trials Forecasted Market Size by Region (2024-2033)
2.3 Pediatric Clinical Trials Market Dynamics
2.3.1 Pediatric Clinical Trials Industry Trends
2.3.2 Pediatric Clinical Trials Market Drivers
2.3.3 Pediatric Clinical Trials Market Challenges
2.3.4 Pediatric Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Clinical Trials Players by Revenue
3.1.1 Global Top Pediatric Clinical Trials Players by Revenue (2018-2023)
3.1.2 Global Pediatric Clinical Trials Revenue Market Share by Players (2018-2023)
3.2 Global Pediatric Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Clinical Trials Revenue
3.4 Global Pediatric Clinical Trials Market Concentration Ratio
3.4.1 Global Pediatric Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Clinical Trials Revenue in 2022
3.5 Pediatric Clinical Trials Key Players Head office and Area Served
3.6 Key Players Pediatric Clinical Trials Product Solution and Service
3.7 Date of Enter into Pediatric Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Clinical Trials Breakdown Data by Type
4.1 Global Pediatric Clinical Trials Historic Market Size by Type (2018-2023)
4.2 Global Pediatric Clinical Trials Forecasted Market Size by Type (2024-2033)
5 Pediatric Clinical Trials Breakdown Data by Application
5.1 Global Pediatric Clinical Trials Historic Market Size by Application (2018-2023)
5.2 Global Pediatric Clinical Trials Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Pediatric Clinical Trials Market Size (2018-2033)
6.2 North America Pediatric Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Pediatric Clinical Trials Market Size by Country (2018-2023)
6.4 North America Pediatric Clinical Trials Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Clinical Trials Market Size (2018-2033)
7.2 Europe Pediatric Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Pediatric Clinical Trials Market Size by Country (2018-2023)
7.4 Europe Pediatric Clinical Trials Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Clinical Trials Market Size (2018-2033)
8.2 Asia-Pacific Pediatric Clinical Trials Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Pediatric Clinical Trials Market Size by Region (2018-2023)
8.4 Asia-Pacific Pediatric Clinical Trials Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Clinical Trials Market Size (2018-2033)
9.2 Latin America Pediatric Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Pediatric Clinical Trials Market Size by Country (2018-2023)
9.4 Latin America Pediatric Clinical Trials Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Clinical Trials Market Size (2018-2033)
10.2 Middle East & Africa Pediatric Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Pediatric Clinical Trials Market Size by Country (2018-2023)
10.4 Middle East & Africa Pediatric Clinical Trials Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA Holdings, Inc.
11.1.1 IQVIA Holdings, Inc. Company Detail
11.1.2 IQVIA Holdings, Inc. Business Overview
11.1.3 IQVIA Holdings, Inc. Pediatric Clinical Trials Introduction
11.1.4 IQVIA Holdings, Inc. Revenue in Pediatric Clinical Trials Business (2018-2023)
11.1.5 IQVIA Holdings, Inc. Recent Development
11.2 Parexel International
11.2.1 Parexel International Company Detail
11.2.2 Parexel International Business Overview
11.2.3 Parexel International Pediatric Clinical Trials Introduction
11.2.4 Parexel International Revenue in Pediatric Clinical Trials Business (2018-2023)
11.2.5 Parexel International Recent Development
11.3 CenterWatch
11.3.1 CenterWatch Company Detail
11.3.2 CenterWatch Business Overview
11.3.3 CenterWatch Pediatric Clinical Trials Introduction
11.3.4 CenterWatch Revenue in Pediatric Clinical Trials Business (2018-2023)
11.3.5 CenterWatch Recent Development
11.4 Syneos Health
11.4.1 Syneos Health Company Detail
11.4.2 Syneos Health Business Overview
11.4.3 Syneos Health Pediatric Clinical Trials Introduction
11.4.4 Syneos Health Revenue in Pediatric Clinical Trials Business (2018-2023)
11.4.5 Syneos Health Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Detail
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Pediatric Clinical Trials Introduction
11.5.4 Charles River Laboratories Revenue in Pediatric Clinical Trials Business (2018-2023)
11.5.5 Charles River Laboratories Recent Development
11.6 Covance Inc.
11.6.1 Covance Inc. Company Detail
11.6.2 Covance Inc. Business Overview
11.6.3 Covance Inc. Pediatric Clinical Trials Introduction
11.6.4 Covance Inc. Revenue in Pediatric Clinical Trials Business (2018-2023)
11.6.5 Covance Inc. Recent Development
11.7 ICON Plc.
11.7.1 ICON Plc. Company Detail
11.7.2 ICON Plc. Business Overview
11.7.3 ICON Plc. Pediatric Clinical Trials Introduction
11.7.4 ICON Plc. Revenue in Pediatric Clinical Trials Business (2018-2023)
11.7.5 ICON Plc. Recent Development
11.8 Pharmaceutical Product Development, LLC.
11.8.1 Pharmaceutical Product Development, LLC. Company Detail
11.8.2 Pharmaceutical Product Development, LLC. Business Overview
11.8.3 Pharmaceutical Product Development, LLC. Pediatric Clinical Trials Introduction
11.8.4 Pharmaceutical Product Development, LLC. Revenue in Pediatric Clinical Trials Business (2018-2023)
11.8.5 Pharmaceutical Product Development, LLC. Recent Development
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Detail
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Pediatric Clinical Trials Introduction
11.9.4 Genentech (Roche) Revenue in Pediatric Clinical Trials Business (2018-2023)
11.9.5 Genentech (Roche) Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Pediatric Clinical Trials Introduction
11.10.4 Pfizer Revenue in Pediatric Clinical Trials Business (2018-2023)
11.10.5 Pfizer Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Detail
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Pediatric Clinical Trials Introduction
11.11.4 Bristol-Myers Squibb Revenue in Pediatric Clinical Trials Business (2018-2023)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Detail
11.12.2 GlaxoSmithKline Business Overview
11.12.3 GlaxoSmithKline Pediatric Clinical Trials Introduction
11.12.4 GlaxoSmithKline Revenue in Pediatric Clinical Trials Business (2018-2023)
11.12.5 GlaxoSmithKline Recent Development
11.13 Sanofi S.A.
11.13.1 Sanofi S.A. Company Detail
11.13.2 Sanofi S.A. Business Overview
11.13.3 Sanofi S.A. Pediatric Clinical Trials Introduction
11.13.4 Sanofi S.A. Revenue in Pediatric Clinical Trials Business (2018-2023)
11.13.5 Sanofi S.A. Recent Development
11.14 Novartis AG
11.14.1 Novartis AG Company Detail
11.14.2 Novartis AG Business Overview
11.14.3 Novartis AG Pediatric Clinical Trials Introduction
11.14.4 Novartis AG Revenue in Pediatric Clinical Trials Business (2018-2023)
11.14.5 Novartis AG Recent Development
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Detail
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson Pediatric Clinical Trials Introduction
11.15.4 Johnson & Johnson Revenue in Pediatric Clinical Trials Business (2018-2023)
11.15.5 Johnson & Johnson Recent Development
11.16 Shire (Takeda)
11.16.1 Shire (Takeda) Company Detail
11.16.2 Shire (Takeda) Business Overview
11.16.3 Shire (Takeda) Pediatric Clinical Trials Introduction
11.16.4 Shire (Takeda) Revenue in Pediatric Clinical Trials Business (2018-2023)
11.16.5 Shire (Takeda) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pediatric Clinical Trials Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Pre-Clinical Phase
Table 3. Key Players of Phase I
Table 4. Key Players of Phase II
Table 5. Key Players of Phase III
Table 6. Global Pediatric Clinical Trials Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Pediatric Clinical Trials Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Pediatric Clinical Trials Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Pediatric Clinical Trials Market Share by Region (2018-2023)
Table 10. Global Pediatric Clinical Trials Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Pediatric Clinical Trials Market Share by Region (2024-2033)
Table 12. Pediatric Clinical Trials Market Trends
Table 13. Pediatric Clinical Trials Market Drivers
Table 14. Pediatric Clinical Trials Market Challenges
Table 15. Pediatric Clinical Trials Market Restraints
Table 16. Global Pediatric Clinical Trials Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Pediatric Clinical Trials Market Share by Players (2018-2023)
Table 18. Global Top Pediatric Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Clinical Trials as of 2022)
Table 19. Ranking of Global Top Pediatric Clinical Trials Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Pediatric Clinical Trials Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pediatric Clinical Trials Product Solution and Service
Table 23. Date of Enter into Pediatric Clinical Trials Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pediatric Clinical Trials Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Pediatric Clinical Trials Revenue Market Share by Type (2018-2023)
Table 27. Global Pediatric Clinical Trials Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Pediatric Clinical Trials Revenue Market Share by Type (2024-2033)
Table 29. Global Pediatric Clinical Trials Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Pediatric Clinical Trials Revenue Market Share by Application (2018-2023)
Table 31. Global Pediatric Clinical Trials Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Pediatric Clinical Trials Revenue Market Share by Application (2024-2033)
Table 33. North America Pediatric Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Pediatric Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Pediatric Clinical Trials Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Pediatric Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Pediatric Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Pediatric Clinical Trials Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Pediatric Clinical Trials Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Pediatric Clinical Trials Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Pediatric Clinical Trials Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Pediatric Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Pediatric Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Pediatric Clinical Trials Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Pediatric Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Pediatric Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Pediatric Clinical Trials Market Size by Country (2024-2033) & (US$ Million)
Table 48. IQVIA Holdings, Inc. Company Detail
Table 49. IQVIA Holdings, Inc. Business Overview
Table 50. IQVIA Holdings, Inc. Pediatric Clinical Trials Product
Table 51. IQVIA Holdings, Inc. Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 52. IQVIA Holdings, Inc. Recent Development
Table 53. Parexel International Company Detail
Table 54. Parexel International Business Overview
Table 55. Parexel International Pediatric Clinical Trials Product
Table 56. Parexel International Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 57. Parexel International Recent Development
Table 58. CenterWatch Company Detail
Table 59. CenterWatch Business Overview
Table 60. CenterWatch Pediatric Clinical Trials Product
Table 61. CenterWatch Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 62. CenterWatch Recent Development
Table 63. Syneos Health Company Detail
Table 64. Syneos Health Business Overview
Table 65. Syneos Health Pediatric Clinical Trials Product
Table 66. Syneos Health Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 67. Syneos Health Recent Development
Table 68. Charles River Laboratories Company Detail
Table 69. Charles River Laboratories Business Overview
Table 70. Charles River Laboratories Pediatric Clinical Trials Product
Table 71. Charles River Laboratories Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 72. Charles River Laboratories Recent Development
Table 73. Covance Inc. Company Detail
Table 74. Covance Inc. Business Overview
Table 75. Covance Inc. Pediatric Clinical Trials Product
Table 76. Covance Inc. Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 77. Covance Inc. Recent Development
Table 78. ICON Plc. Company Detail
Table 79. ICON Plc. Business Overview
Table 80. ICON Plc. Pediatric Clinical Trials Product
Table 81. ICON Plc. Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 82. ICON Plc. Recent Development
Table 83. Pharmaceutical Product Development, LLC. Company Detail
Table 84. Pharmaceutical Product Development, LLC. Business Overview
Table 85. Pharmaceutical Product Development, LLC. Pediatric Clinical Trials Product
Table 86. Pharmaceutical Product Development, LLC. Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 87. Pharmaceutical Product Development, LLC. Recent Development
Table 88. Genentech (Roche) Company Detail
Table 89. Genentech (Roche) Business Overview
Table 90. Genentech (Roche) Pediatric Clinical Trials Product
Table 91. Genentech (Roche) Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 92. Genentech (Roche) Recent Development
Table 93. Pfizer Company Detail
Table 94. Pfizer Business Overview
Table 95. Pfizer Pediatric Clinical Trials Product
Table 96. Pfizer Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Bristol-Myers Squibb Company Detail
Table 99. Bristol-Myers Squibb Business Overview
Table 100. Bristol-Myers Squibb Pediatric Clinical Trials Product
Table 101. Bristol-Myers Squibb Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 102. Bristol-Myers Squibb Recent Development
Table 103. GlaxoSmithKline Company Detail
Table 104. GlaxoSmithKline Business Overview
Table 105. GlaxoSmithKline Pediatric Clinical Trials Product
Table 106. GlaxoSmithKline Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 107. GlaxoSmithKline Recent Development
Table 108. Sanofi S.A. Company Detail
Table 109. Sanofi S.A. Business Overview
Table 110. Sanofi S.A. Pediatric Clinical Trials Product
Table 111. Sanofi S.A. Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 112. Sanofi S.A. Recent Development
Table 113. Novartis AG Company Detail
Table 114. Novartis AG Business Overview
Table 115. Novartis AG Pediatric Clinical Trials Product
Table 116. Novartis AG Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 117. Novartis AG Recent Development
Table 118. Johnson & Johnson Company Detail
Table 119. Johnson & Johnson Business Overview
Table 120. Johnson & Johnson Pediatric Clinical Trials Product
Table 121. Johnson & Johnson Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 122. Johnson & Johnson Recent Development
Table 123. Shire (Takeda) Company Detail
Table 124. Shire (Takeda) Business Overview
Table 125. Shire (Takeda) Pediatric Clinical Trials Product
Table 126. Shire (Takeda) Revenue in Pediatric Clinical Trials Business (2018-2023) & (US$ Million)
Table 127. Shire (Takeda) Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Clinical Trials Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Pediatric Clinical Trials Market Share by Type: 2022 VS 2033
Figure 3. Pre-Clinical Phase Features
Figure 4. Phase I Features
Figure 5. Phase II Features
Figure 6. Phase III Features
Figure 7. Global Pediatric Clinical Trials Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Pediatric Clinical Trials Market Share by Application: 2022 VS 2033
Figure 9. Neuropsychiatric Conditions Case Studies
Figure 10. Infectious Diseases Case Studies
Figure 11. Respiratory Diseases Case Studies
Figure 12. Cardiovascular Diseases Case Studies
Figure 13. Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Pediatric Clinical Trials Report Years Considered
Figure 16. Global Pediatric Clinical Trials Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Pediatric Clinical Trials Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Pediatric Clinical Trials Market Share by Region: 2022 VS 2033
Figure 19. Global Pediatric Clinical Trials Market Share by Players in 2022
Figure 20. Global Top Pediatric Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Clinical Trials as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Pediatric Clinical Trials Revenue in 2022
Figure 22. North America Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Pediatric Clinical Trials Market Share by Country (2018-2033)
Figure 24. United States Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Pediatric Clinical Trials Market Share by Country (2018-2033)
Figure 28. Germany Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Pediatric Clinical Trials Market Share by Region (2018-2033)
Figure 36. China Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Pediatric Clinical Trials Market Share by Country (2018-2033)
Figure 44. Mexico Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Pediatric Clinical Trials Market Share by Country (2018-2033)
Figure 48. Turkey Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Pediatric Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. IQVIA Holdings, Inc. Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 51. Parexel International Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 52. CenterWatch Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 53. Syneos Health Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 54. Charles River Laboratories Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 55. Covance Inc. Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 56. ICON Plc. Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 57. Pharmaceutical Product Development, LLC. Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 58. Genentech (Roche) Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 59. Pfizer Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 62. Sanofi S.A. Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 63. Novartis AG Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 64. Johnson & Johnson Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 65. Shire (Takeda) Revenue Growth Rate in Pediatric Clinical Trials Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed